Browse: Home / 2013 / November / 18 / IBM, Munich University, DOE Lab Researchers Analyze Bubbles for Healthcare Simulation
November 25, 2021
Header image

GovCon ExecLogo

Private-Public Connections for Contract Leadership

Menu

Skip to content
  • Home
  • About
  • Wash 100
  • Advertise
  • Posts from ExecutiveBiz for 01/04/2019
  • Posts from GovConWire for 01/04/2019
  • Posts from GovConDaily for 01/03/2019
  • Posts from ExecutiveBiz for 01/03/2019
  • Posts from GovConDaily for 01/02/2019
  • Posts from GovConWire for 01/03/2019
  • Posts from ExecutiveBiz for 01/02/2019
  • Posts from GovConWire for 01/02/2019
  • Posts from GovConDaily for 12/28/2018
  • Posts from ExecutiveBiz for 12/28/2018

IBM, Munich University, DOE Lab Researchers Analyze Bubbles for Healthcare Simulation

Posted by Ross Wilkers on November 18, 2013 in News | 32 Views

A team of scientists from IBM, ETH Zurich, Technical University of Munich and the Lawrence Livermore National Laboratory have collaborated to simulate fluid dynamics in a move aimed at addressing healthcare and industrial needs.

Scientists used 6.4 million threads on LLNL’s 96 rack Sequoia IBM BlueGene/Q supercomputers to analyze the occurrence of bubbles collapsing inward for potential usages in designing fuel injectors and propellers, crushing kidney stones using high pressure and developing cancer therapies, IBM said Monday.

The team conducted the simulation using 13 trillion cells and reached 14.4 Petaflop sustained performance on Sequoia.

Petros Koumoutsakos, director of the Computational Science and Engineering Laboratory at ETH Zurich, said the team based the developments on finite volume procedures.

“We have also invested significant effort in designing software that takes advantage of todays parallel computer architectures,” Koumoutsakos adds.

Scientists resolved 15,000 bubbles and the result is expected to help further the analysis of cloud cavitation collapse phenomenon in which pressure variations cause vapor cavities to form in a liquid and bubbles to implode to create shockwaves for potential healthcare and industrial applications.

Alessandro Curioni, head of mathematical and computational sciences department at IBM Research – Zurich, said the team achieved that development by using hardware and software tools within the IBM BlueGene/Q platform.

Posted in News | Tagged cancer, ETH Zurich, IBM, kidney stones, Lawrence Livermore National Laboratory, partnership, research, simulation, Technical University of Munich

About the Author

Ross Wilkers

Related Posts

Lisa Mascolo, IBM Global Business Sector’s Managing Director, Inducted Into 2018 Wash100 for Cloud & Analytics Service Excellence→

Chuck Prow, President and CEO of Vectrus, Selected to 2018 Wash100 For His Vision and Implementation of Key Growth Initiatives→

Sam Gordy, IBM Federal GM, Chosen to 2018 Wash100 for Leadership in Technological Innovation and Support of Service Members→

Doug Lane, CEO of Capgemini Government Solutions, Inducted Into 2018 Wash100 for Customer Engagement and Strategic Consulting Leadership→

Click here to sign up for all of our E-NewsWires

Subscribe to all our E-NewsWires

Subscriber Details

Upcoming POC Event

Sponsor Ad

©2015 GovCon Exec

Menu

  • Authors
  • Sitemap
  • Contact Us
Show Buttons
Hide Buttons